Previous 10 | Next 10 |
2024-06-06 07:00:00 ET The medicine for type 2 diabetes called Ozempic is, without a doubt, Novo Nordisk 's (NYSE: NVO) knight in shining armor. Thanks to an impressive amount of demand and the company's dedicated efforts in exploring other conditions that the medicine could potenti...
2024-06-05 13:44:31 ET More on LifeMD LifeMD: Moving Towards Profitability LifeMD, Inc. (LFMD) Q1 2024 Earnings Call Transcript LifeMD, Inc. 2024 Q1 - Results - Earnings Call Presentation LifeMD Q1 2024 Earnings Preview LifeMD Non-GAAP EPS of $0.15 be...
A look at the top 10 most actives in the United States SOBR Safe Inc. (SOBR) rose 74.6% to $0.46 on volume of 265,324,361 shares MicroAlgo Inc. (MLGO) rose 669.9% to $12.01 on volume of 183,977,846 shares PROSHARES TRUST (SQQQ) fell 0.7% to $9.86 on volume of 124,114,596 shares Faraday ...
2024-06-04 14:57:26 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly and Company (LLY) Lilly Oncology ASCO Investor Event (Transcript) Eli Lilly's Growth And Challenges: A Cautious Buy Novo Nordisk: The Market Is Right, Don't Fight Against It Eli Lilly sees...
2024-06-04 13:50:00 ET Summary More than 800 million people are estimated to be overweight or obese worldwide, and the growing prevalence of obesity, despite the availability of various treatments, suggests that isn’t going to change. The potential $500 billion market for G...
2024-06-04 09:53:00 ET Novo Nordisk 's (NYSE: NVO) type 2 diabetes drug Ozempic is a sensation, and it's no surprise why. In the first quarter, revenue from Ozempic rose 35% year over year to reach roughly $4.3 billion, and there's no sign of a slowdown in sight. In fact, it's v...
2024-06-03 20:03:51 ET Summary Soros Fund Management's 13F portfolio value decreased from $7.65B to $6.02B in Q1 2024. New stakes include Cloudflare Inc. Puts, Cerevel Therapeutics, and Aramark. Stake disposals include Apple Puts, PDD Holdings Puts, and SPDR Index Euro Stocks ...
Novo Nordisk launches national Wegovy® campaign, Power of Wegovy® PR Newswire Designed to celebrate diverse, unique portrayals of individuals who partner with their healthcare professional to change the course of their weight-management journey, while educating on ...
2024-06-03 08:10:00 ET Summary Amazon CEO Andy Jassy highlights key traits for success in a career professional, including working hard, being can-do, and following through on commitments. There are different paths to success, and income investors can potentially achieve a high le...
2024-06-02 10:00:00 ET More on Amgen, Structure Therapeutics, etc. Novo Nordisk: The Market Is Right, Don't Fight Against It Novo Nordisk: Not The Best Investment Right Now, But A Great Case Study Pfizer: The Chart Looks Like A Bottom, But Is The Dividend Safe? ...
News, Short Squeeze, Breakout and More Instantly...
Novo Nordisk A/S Company Name:
NVO Stock Symbol:
NYSE Market:
2024-06-30 09:15:00 ET Novo Nordisk (NYSE: NVO) has emerged as one of the biggest names in the pharmaceutical world thanks to its robust line of glucagon-like peptide-1 (GLP-1) medicines. The Danish drugmaker develops Ozempic, Rybelsus, Saxenda, and Wegovy. While Ozempic is appr...
2024-06-29 11:34:00 ET For most of its existence, Altimmune (NASDAQ: ALT) has been a little-known biotech aspiring to compete in a world dominated by whales like Novo Nordisk (NYSE: NVO) , the maker of the hit weight loss drug Wegovy and the blockbuster Ozempic for type 2 di...
2024-06-25 10:45:03 ET Regis Corp. (RGS) RGS is trading UP for the last 5 days, and it at trading at $15.94 with volume of 27,015,876 and a one day change of $10.87 (214.86%). Regis Corp. has a 52-week low of 0.31 and a 52-week high of $15.24. The business's 50-day moving average pr...